» Articles » PMID: 31561625

Characteristics of Gut Microbiota in Patients with Hypertension And/or Hyperlipidemia: A Cross-Sectional Study on Rural Residents in Xinxiang County, Henan Province

Overview
Journal Microorganisms
Specialty Microbiology
Date 2019 Sep 29
PMID 31561625
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Human gut microbiota can be affected by a variety of factors, including geography. This study aimed to clarify the regional specific characteristics of gut microbiota in rural residents of Xinxiang county, Henan province, with hypertension and hyperlipidemia and evaluate the association of specific gut microbiota with hypertension and hyperlipidemia clinical indices. To identify the gut microbes, 16S rRNA gene sequencing was used and a random forest disease classifier was constructed to discriminate between the gut microbiota in hypertension, hyperlipidemia, and the healthy control. Patients with hypertension and hyperlipidemia presented with marked gut microbiota dysbiosis compared to the healthy control. The gut microbiota related to hypertension and hyperlipidemia may consist of a large number of taxa, influencing each other in a complex metabolic network. Examining the top 35 genera in each group showed that , or abundances were positively correlated with systolic blood pressure (SBP) or diastolic blood pressure (DBP) in hypertensive patients with treatment-naive hypertension ( = 63). In hypertensive patients undergoing anti-hypertensive treatment ( = 104), the abundance of or was positively correlated to SBP. In the hyperlipidemia group, some of the top 35 genera were significantly correlated to triglyceride, total cholesterol, and fasting blood glucose levels. This study analyzed the characteristics of the gut microbiota in patients with hypertension and/or hyperlipidemia, providing a theoretical basis for the prevention and control of hypertension and hyperlipidemia in this region.

Citing Articles

Gut microbiota and gut-derived metabolites are altered and associated with dietary intake in women with polycystic ovary syndrome.

da Silva T, Marchesan L, Rampelotto P, Longo L, de Oliveira T, Landberg R J Ovarian Res. 2024; 17(1):232.

PMID: 39578890 PMC: 11583432. DOI: 10.1186/s13048-024-01550-w.


Intestinal microbiota by angiotensin receptor blocker therapy exerts protective effects against hypertensive damages.

Li J, Wang S, Yan K, Wang P, Jiao J, Wang Y Imeta. 2024; 3(4):e222.

PMID: 39135690 PMC: 11316932. DOI: 10.1002/imt2.222.


Probiotics combined with atorvastatin administration in the treatment of hyperlipidemia: A randomized, double-blind, placebo-controlled clinical trial.

Tian Y, Wu G, Zhao X, Zhang H, Ren M, Song X Medicine (Baltimore). 2024; 103(21):e37883.

PMID: 38788020 PMC: 11124713. DOI: 10.1097/MD.0000000000037883.


Gut Microbiota Modulation by Selenium and Zinc Enrichment Postbiotic on Dysbiosis Associated with Hypertension.

Dinu L, Gatea F, Matei F, Banciu C, Vamanu E Curr Vasc Pharmacol. 2024; 22(5):365-374.

PMID: 38779729 DOI: 10.2174/0115701611290537240509061549.


Research Progress on the Correlation Between Hypertension and Gut Microbiota.

Cui X, Zhang T, Xie T, Guo F, Zhang Y, Deng Y J Multidiscip Healthc. 2024; 17:2371-2387.

PMID: 38770171 PMC: 11104380. DOI: 10.2147/JMDH.S463880.


References
1.
Ren Z, Li A, Jiang J, Zhou L, Yu Z, Lu H . Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut. 2018; 68(6):1014-1023. PMC: 6580753. DOI: 10.1136/gutjnl-2017-315084. View

2.
Fava C, Sjogren M, Montagnana M, Danese E, Almgren P, Engstrom G . Prediction of blood pressure changes over time and incidence of hypertension by a genetic risk score in Swedes. Hypertension. 2012; 61(2):319-26. DOI: 10.1161/HYPERTENSIONAHA.112.202655. View

3.
Linz D, Wirth K, Linz W, Heuer H, Frick W, Hofmeister A . Antihypertensive and laxative effects by pharmacological inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut. Hypertension. 2012; 60(6):1560-7. DOI: 10.1161/HYPERTENSIONAHA.112.201590. View

4.
Wei Q, Sun J, Huang J, Zhou H, Ding Y, Tao Y . Prevalence of hypertension and associated risk factors in Dehui City of Jilin Province in China. J Hum Hypertens. 2014; 29(1):64-8. DOI: 10.1038/jhh.2014.32. View

5.
Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G . Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome. 2017; 5(1):14. PMC: 5286796. DOI: 10.1186/s40168-016-0222-x. View